March 12, 2025
LEAST Study to Test Type 2 Diabetes Medication for Stroke Recovery
PHRI researchers are looking into whether liraglutide, a widely used medication for type 2 diabetes, could benefit patients with large...
Read More
March 7, 2025
OCEANIC-STROKE Completes Recruitment, Exceeds Target
PHRI’s OCEANIC-STROKE study has successfully completed recruitment enrolling approximately 12,300 patients across 38 countries, surpassing its initial target of 9,300...
Read More
February 25, 2025
CLARITY for Better Chronic Limb-Threatening Ischemia Treatment
PHRI has received a $244,800 grant from the Canadian Institutes of Health Research (CIHR) for a new study that aims...
Read More
February 10, 2025
PHRI at ISC 2025
Several PHRI researchers presented at the International Stroke Congress (ISC) 2025, held in Los Angeles, California, from February 5-7, 2025. ...
Read More
February 6, 2025
Secondary CVD Medications Remain Underused Globally
A recent PURE study has found that secondary prevention medications for cardiovascular diseases (CVD), which help prevent further health complications,...
Read More
February 3, 2025
Apixaban Reduces Stroke Risk More Than It Increases Bleeding in Stroke Survivors
An analysis of the ARTESiA study found that the blood thinner apixaban helps prevent stroke in people with device-detected subclinical...
Read More
January 23, 2025
Jason Roberts Named Inaugural Chair in ARVC Research
PHRI Scientist Jason Roberts has been named as the inaugural Marianne Barrie/PHRI Chair in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Research,...
Read More
December 19, 2024
Strengthening Clinical Research Capacity at PHRI with CANTRAIN
Driven by its commitment to operational excellence and advancing clinical research, PHRI is proud to be among the first to...
Read More
December 16, 2024
CVCT Global Forum 2024
At the CVCT 2024 Global Forum, PHRI researchers delivered a range of presentations on cardiovascular research design and inclusivity, and the...
Read More
December 13, 2024
Pushing the Boundaries of Interim Analysis in Clinical Trials
Monitoring clinical trials that evaluate the effectiveness and safety of a treatment or intervention is key to ensuring data accuracy,...
Read More
December 10, 2024
2024 CHS Paper of the Year Award for STRATUS
PHRI Associate Senior Scientist Deborah Siegal received the 2024 Canadian Hematology Society (CHS) Paper of the Year for the “Small-Volume...
Read More
December 6, 2024
7th Annual Janice Pogue Lecture: Is it Time to Modernize Clinical Trials Design?
This week, we had the pleasure of hosting Dr. Frank Harrell for the Seventh Annual Janice Pogue Lecture in Biostatistics....
Read More
November 28, 2024
PHRI Turns 25: Building on Progress for the Future
More than 150 local and international researchers gathered for PHRI’s “Building on Progress for the Future” scientific symposium to celebrate...
Read More
November 21, 2024
PHRI Marks 25 Years of Pioneering Global Health Research and Innovation
PHRI’s discoveries have shaped patient care, from Hamilton’s local hospitals to World Health Organization guidelines The Population Health Research Institute...
Read More
November 20, 2024
PHRI Researchers Among World’s Highly Cited
Four PHRI researchers have been named to the prestigious Clarivate Highly Cited Researchers 2024 list, which recognizes individuals for their...
Read More